Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heparan sulfate proteoglycans (HSPGs) are ubiquitous glycoproteins found on the cell surface and within the extracellular matrix, consisting of a core protein covalently linked to heparan sulfate glycosaminoglycan chains. In the context of viral infections, particularly SARS-CoV-2, HSPGs serve as essential co-receptors that facilitate the initial attachment of the virus to the host cell membrane (Clausen et al., 2020, Cell). The viral spike protein interacts with the negatively charged sulfate groups on the HSPG chains, which promotes a conformational change or increases the local concentration of the virus, allowing it to efficiently engage its primary receptor, Angiotensin-converting enzyme 2 (ACE2). This interaction forms a ternary complex (Spike-HSPG-ACE2) that is critical for viral entry and subsequent infection. Because of this role, HSPGs and their associated interfaces are significant therapeutic targets; heparin and other glycan mimetics are being explored to competitively inhibit viral binding and reduce infectivity. Beyond viral entry, HSPGs are involved in regulating various physiological processes, including inflammation and tumor metastasis, making them versatile but complex targets for drug development.
Competitive inhibition of viral spike protein binding to host cell surface heparan sulfate proteoglycans, thereby preventing the formation of the ternary complex required for ACE2-mediated viral entry.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heparan sulfate proteoglycan co-receptor (HSPG).